SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Nortran Pharmaceutical -NRT.V
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ms. Forthright who wrote (714)5/15/1998 11:08:00 AM
From: Wisee  Read Replies (2) of 1185
 
Ms. Forthright,

It was my pleasure to meet you & Edward at the AGM. We too were very impressed with Robert Rieder and Dr. Michael Walker's presentation.

After the AGM, we were very fortunate to meet several analysts that
are presently working on research reports on NRT.
They ALL agreed that NRT is presently undervalued!!
Expect BUY recommendations to come out shortly, with one year targets of between $4-$6.

Wisee
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News